Literature DB >> 16763198

Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells.

Francisco J Rivera1, Sebastien Couillard-Despres, Xiomara Pedre, Sonja Ploetz, Massimiliano Caioni, Carlos Lois, Ulrich Bogdahn, Ludwig Aigner.   

Abstract

Adult stem cells reside in different tissues and organs of the adult organism. Among these cells are MSCs that are located in the adult bone marrow and NSCs that exist in the adult central nervous system (CNS). In transplantation experiments, MSCs demonstrated neuroprotective and neuroregenerative effects that were associated with functional improvements. The underlying mechanisms are largely unidentified. Here, we reveal that the interactions between adult MSCs and NSCs, mediated by soluble factors, induce oligodendrogenic fate decision in NSCs at the expense of astrogenesis. This was demonstrated (a) by an increase in the percentage of cells expressing the oligodendrocyte markers GalC and myelin basic protein, (b) by a reduction in the percentage of glial fibrillary acidic protein (GFAP)-expressing cells, and (c) by the expression pattern of cell fate determinants specific for oligodendrogenic differentiation. Thus, it involved enhanced expression of the oligodendrogenic transcription factors Olig1, Olig2, and Nkx2.2 and diminished expression of Id2, an inhibitor of oligodendrogenic differentiation. Results of (a) 5-bromo-2'-deoxyuridine pulse-labeling of cells, (b) cell fate analysis, and (c) cell death/survival analysis suggested an inductive mechanism and excluded a selection process. A candidate factor screen excluded a number of growth factors, cytokines, and neurotrophins that have previously been shown to influence neurogenesis and neural differentiation from the oligodendrogenic activity derived from the MSCs. This work might have major implications for the development of future transplantation strategies for the treatment of degenerative diseases in the CNS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763198     DOI: 10.1634/stemcells.2005-0614

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  46 in total

1.  Mesenchymal stem cells prime proliferating adult neural progenitors toward an oligodendrocyte fate.

Authors:  Carolin Steffenhagen; Franz-Xaver Dechant; Eleni Oberbauer; Tanja Furtner; Norbert Weidner; Patrick Küry; Ludwig Aigner; Francisco J Rivera
Journal:  Stem Cells Dev       Date:  2011-12-23       Impact factor: 3.272

Review 2.  The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.

Authors:  Jeffery J Auletta; Amelia M Bartholomew; Richard T Maziarz; Robert J Deans; Robert H Miller; Hillard M Lazarus; Jeffrey A Cohen
Journal:  Immunotherapy       Date:  2012-05       Impact factor: 4.196

3.  Adult stem cells and multiple sclerosis.

Authors:  N Scolding
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

Review 4.  Mesenchymal stem cell transplantation in multiple sclerosis.

Authors:  Jeffrey A Cohen
Journal:  J Neurol Sci       Date:  2013-01-04       Impact factor: 3.181

5.  Human stem/progenitor cells from bone marrow enhance glial differentiation of rat neural stem cells: a role for transforming growth factor β and Notch signaling.

Authors:  Andrew P Robinson; Jessica E Foraker; Joni Ylostalo; Darwin J Prockop
Journal:  Stem Cells Dev       Date:  2010-09-14       Impact factor: 3.272

6.  Effect of stem cells-based therapy on astrogliosis in stroke subjected-mice.

Authors:  Kobra Akhoundzadeh; Abedin Vakili
Journal:  Stem Cell Investig       Date:  2020-12-15

Review 7.  Neuroprotection Strategies in Preterm Encephalopathy.

Authors:  Pratik Parikh; Sandra E Juul
Journal:  Semin Pediatr Neurol       Date:  2019-08-09       Impact factor: 1.636

8.  Adult human mesenchymal cells proliferate and migrate in response to chemokines expressed in demyelination.

Authors:  Claire M Rice; Neil J Scolding
Journal:  Cell Adh Migr       Date:  2010-04-03       Impact factor: 3.405

9.  Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats.

Authors:  Cindy T van Velthoven; Mark Dzietko; Michael F Wendland; Nikita Derugin; Joel Faustino; Cobi J Heijnen; Donna M Ferriero; Zinaida S Vexler
Journal:  J Neurosci Res       Date:  2016-10-26       Impact factor: 4.164

10.  Cyclin-dependent kinase 4 signaling acts as a molecular switch between syngenic differentiation and neural transdifferentiation in human mesenchymal stem cells.

Authors:  Janet Lee; Jeong-Hwa Baek; Kyu-Sil Choi; Hyun-Soo Kim; Hye-Young Park; Geun-Hyoung Ha; Ho Park; Kyo-Won Lee; Chang Geun Lee; Dong-Yun Yang; Hyo Eun Moon; Sun Ha Paek; Chang-Woo Lee
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.